|
|
|
| |
|
|
| |
The latest drug discovery news from News Medical |
|
|
|
 | | |
 Addressing key challenges in drug discovery and development
Escalating costs and increasing demands from regulatory authorities for a precision medicine-based approach to drug development challenge the pharmaceutical industry. Olink’s PEA technology supports drug target discovery and the analysis of clinical trial samples, enabling biomarker-defined subgroup exploration, assessment of pharmacodynamic responses, and deeper insights into disease biology and drug mechanisms.
| |
|
|
|
|
| | |  Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine. | | | | |  Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. | | | | |  A multinational team of researchers has made a significant advance in the manufacturing of doxorubicin, a crucial chemotherapy drug. | | | | |  Urologists at Vanderbilt Health are enrolling men with stress urinary incontinence (SUI) in a clinical trial named SOPHIA2 to assess the safety and efficacy of the UroActive implant, following an investigational device exemption clearance from the U.S. Food and Drug Administration and the French National Agency for the Safety of Medicines and Health Products. | | | | |  A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. | |
|
|
|
 | | | How would you rate today's newsletter?
| |
|
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
